Surrozen, Inc. (SRZN) DCF Valuation

Valoración de DCF Surrozen, Inc. (SRZN)

US | Healthcare | Biotechnology | NASDAQ
Surrozen, Inc. (SRZN) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Surrozen, Inc. (SRZN) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Mejore sus opciones de inversión con la calculadora DCF Surrozen, Inc. (SRZN)! Explore los datos financieros reales para Surrozen, ajuste las proyecciones y gastos de crecimiento, y vea instantáneamente cómo estos ajustes afectan el valor intrínseco de Surrozen, Inc. (SRZN).


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 12.5 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 -100 -25 -25 -25 -25 -25
EBITDA -22.8 -31.4 -51.4 -42.4 -41.1 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 -339.07 100 60 60 60 60 60
Depreciation 2.3 2.9 3.3 3.3 1.9 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 26.15 100 85.23 85.23 85.23 85.23 85.23
EBIT -25.1 -34.3 -54.6 -45.7 -43.0 .0 .0 .0 .0 .0
EBIT, % 100 100 100 -365.22 100 60 60 60 60 60
Total Cash 29.1 49.2 101.9 75.8 36.0 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 2.0 2.2
Account Receivables, % 100 100 100 15.82 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 0 100 80 80 80 80 80
Accounts Payable 1.0 1.8 2.7 .7 .5 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 5.26 100 81.05 81.05 81.05 81.05 81.05
Capital Expenditure -1.6 -.9 -1.3 -.7 -.4 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 -5.82 100 -1.16 -1.16 -1.16 -1.16 -1.16
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -25.1 -34.2 -52.5 -35.1 -43.0 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -23.4 -31.3 -49.5 -36.6 -41.8 1.6 .0 .0 .0 .0
WACC, % 8.41 8.41 8.4 8.3 8.41 8.39 8.39 8.39 8.39 8.39
PV UFCF
SUM PV UFCF 1.5
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 2
Net Debt -33
Equity Value 34
Diluted Shares Outstanding, MM 2
Equity Value Per Share 16.93

What You Will Gain

  • Comprehensive Financial Model: Surrozen’s actual data facilitates accurate DCF valuation.
  • Complete Forecast Flexibility: Modify revenue growth, profit margins, WACC, and other essential variables.
  • Real-Time Calculations: Immediate updates ensure you view results as adjustments are made.
  • Professional-Grade Template: A polished Excel file crafted for high-quality valuation.
  • Adaptable and Repeatable: Designed for versatility, allowing for ongoing use in detailed forecasting.

Key Features

  • Real-Life SRZN Data: Pre-filled with Surrozen’s historical financials and future projections.
  • Fully Customizable Inputs: Modify revenue growth, profit margins, WACC, tax rates, and capital expenditures as needed.
  • Dynamic Valuation Model: Automatic updates to Net Present Value (NPV) and intrinsic value based on your adjustments.
  • Scenario Testing: Develop various forecast scenarios to evaluate different valuation possibilities.
  • User-Friendly Design: Intuitive, organized, and suitable for both professionals and newcomers.

How It Works

  • 1. Access the Template: Download and open the Excel file containing Surrozen, Inc. (SRZN)'s preloaded data.
  • 2. Adjust Assumptions: Modify key inputs such as growth rates, WACC, and capital expenditures relevant to Surrozen, Inc. (SRZN).
  • 3. View Results Instantly: The DCF model automatically calculates the intrinsic value and NPV for Surrozen, Inc. (SRZN).
  • 4. Explore Scenarios: Analyze various forecasts to assess different valuation outcomes for Surrozen, Inc. (SRZN).
  • 5. Present with Confidence: Share professional valuation insights for Surrozen, Inc. (SRZN) to bolster your decision-making process.

Why Choose This Calculator for Surrozen, Inc. (SRZN)?

  • Designed for Experts: A specialized tool utilized by investors, analysts, and biotech consultants.
  • Accurate Data: Surrozen’s historical and projected financials are preloaded for precise analysis.
  • Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
  • Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
  • User-Friendly: Step-by-step guidance ensures a smooth calculation process.

Who Should Use This Product?

  • Professional Investors: Develop comprehensive and accurate valuation models for analyzing Surrozen, Inc. (SRZN) stock.
  • Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
  • Consultants and Advisors: Deliver precise valuation insights to clients regarding Surrozen, Inc. (SRZN).
  • Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
  • Biotechnology Enthusiasts: Gain insights into how biotech companies like Surrozen, Inc. (SRZN) are valued in the market.

What the Surrozen, Inc. (SRZN) Template Contains

  • Pre-Filled Data: Includes Surrozen’s historical financials and projections.
  • Discounted Cash Flow Model: Editable DCF valuation model with automated calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on user-defined inputs.
  • Key Financial Ratios: Assess Surrozen’s profitability, efficiency, and leverage metrics.
  • Customizable Inputs: Easily modify revenue growth, profit margins, and tax rates.
  • Clear Dashboard: Visuals and tables summarizing essential valuation outcomes.

No products were found matching.